Cargando…
COVID-19 and comedications in atrial fibrillation—a case–control study in Stockholm
To test the main hypothesis that anticoagulation reduces risk of hospitalization, intensive care unit (ICU) admission and death in COVID-19. Nested case–control study among patients with atrial fibrillation (AF) in Stockholm. COVID-19 cases were matched to five disease-free controls with same sex, b...
Autores principales: | Bell, Max, Ekbom, Anders, Linder, Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883132/ https://www.ncbi.nlm.nih.gov/pubmed/36707492 http://dx.doi.org/10.1007/s10654-023-00967-9 |
Ejemplares similares
-
Risk factors for COVID-19-related death, hospitalization and intensive care: a population-wide study of all inhabitants in Stockholm
por: Hergens, Maria-Pia, et al.
Publicado: (2022) -
Pharmacotherapy of atrial fibrillation in COVID-19 patients
por: Tomaszuk-Kazberuk, Anna, et al.
Publicado: (2021) -
New-onset atrial fibrillation during COVID-19 infection predicts poor prognosis
por: Sanz, Ana Pardo, et al.
Publicado: (2021) -
Remote proctoring for cryoballoon ablation of atrial fibrillation: A challenge or an opportunity in the COVID-19 era?
por: Glowniak, Andrzej, et al.
Publicado: (2021) -
Atrial fibrillation is related to higher mortality in COVID-19/SARS-CoV-2 pneumonia infection
por: Denegri, Andrea, et al.
Publicado: (2021)